Skip to content

Evaluation of the effect of a hair serum on hair growth and anti-greying in adult participants.

A clinical study to evaluate the hair growth and anti-grey efficacy of a hair serum in adult trial participants over 12 weeks. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/107039
Enrollment
38
Registered
2026-03-30
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Vilvah Store Hair Growth Serum: The test product will be applied once daily at night for a duration of 12 weeks. The product will be applied evenly over the scalp and gently massaged. P

Sponsors

Vilvah Store Private Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Male & Female trial participants in general good health. 2. Male & Female trial participants in the age group 20-55 years (both the ages inclusive), preferably in equal distribution. 3. Trial participants with at least 15-25% of grey hair (considering overall scalp area) based on dermatologist discretion. 4. Trial participants who are non-regular users of hair colour / hair dye and have not applied henna/ hair colour etc, for the past 1 month or more before screening visit (self-declared). 5. Trial participants who have not participated in a similar investigation in the past one month. 6. Trial participants complaining of hair fall and damage.

Exclusion criteria

Exclusion criteria: 1. Trial participants who have undergone hair growth treatment within 1 month before screening into the study. 2. Trial participants using medicated oil/shampoo etc. for treatment of grey hair/ hair fall will be excluded 3. Trial participants having any active scalp disease which may interfere in the study dermatologist s judgement. 4. Trial participants who have taken chemotherapy for cancer in the last 6 months prior to start of the study or have a plan to do treatments during study. 5. Trial participants who have history of alcoholism and/or psychiatric disorder including trichotillomania. 6. Trial participants who have had hair transplant.

Design outcomes

Primary

MeasureTime frame
Reduction in grey hair, improvement in hair growth, density, and thickness, as assessed by cutiscope imaging, trichoscan analysis, Denolite imaging, and dermatological evaluation at different time points compared to baselineTimepoint: Baseline, Week 4, Week 8, Week 12

Secondary

MeasureTime frame
Overall improvement in the condition of hair in comparison to baseline and safety evaluation of test products.Timepoint: Baseline, Week 4, Week 8, Week 12

Countries

India

Contacts

Public ContactSudhanthiran S

MS Clinical Research Pvt. Ltd

ritambhara@msclinical.com08040917253

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026